Intellia Therapeutics, Inc NTLA
$11.91
+0.68%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (11 Buy · 6 Hold · 3 Sell)
- Average Price Target
- $20.90
- Implied Upside
- +75.5%
- Price Target Range
- $5.00 – $49.00
- Analysts (12 mo)
- 20
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | Evercore ISI GroupJonathan Miller |
Upgrades | In-line → Outperform | $16 → $24 |
| 2026-07-16 | Wolfe ResearchAndy Chen |
Downgrades | Peer perform → Underperform | $9 |
| 2026-07-10 | WedbushDavid Nierengarten |
Maintains | Neutral | $12 → $17 |
| 2026-06-16 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $49 |
| 2026-06-15 | CitizensSilvan Turkcan |
Reiterates | Market outperform | $30 |
| 2026-06-15 | WedbushDavid Nierengarten |
Reiterates | Neutral | $12 |
| 2026-06-15 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $25 |
| 2026-05-13 | BernsteinWilliam Pickering |
Maintains | Market perform | $13 → $17 |
| 2026-05-13 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $30 → $25 |
| 2026-05-12 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $58 → $49 |
| 2026-05-12 | WedbushDavid Nierengarten |
Reiterates | Neutral | $12 |
| 2026-04-28 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $48 → $58 |
| 2026-04-28 | Goldman SachsSalveen Richter |
Maintains | Sell | $8 → $9 |
| 2026-04-28 | Morgan StanleyTerence Flynn |
Maintains | Equal-weight | $11 → $15 |
| 2026-04-28 | CitizensSilvan Turkcan |
Maintains | Market outperform | $28 → $30 |
| 2026-04-27 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $27 → $30 |
| 2026-04-27 | BairdJack Allen |
Maintains | Neutral | $7 → $13 |
| 2026-03-04 | Jones TradingDebanjana Chatterjee |
Upgrades | Hold → Buy | $29 |
| 2026-03-03 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $54 → $48 |
| 2026-03-03 | Leerink PartnersMani Foroohar |
Maintains | Outperform | $27 → $29 |
| 2026-03-03 | RBC CapitalLuca Issi |
Maintains | Sector perform | $9 → $15 |
| 2026-03-03 | Wells FargoYanan Zhu |
Maintains | Equal-weight | $12 → $15 |
| 2026-03-03 | CitizensSilvan Turkcan |
Maintains | Market outperform | $21 → $28 |
| 2026-03-03 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $25 → $30 |
| 2026-03-02 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $26 → $27 |
| 2026-02-27 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $26 |
| 2026-01-28 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $15 → $25 |
| 2025-11-12 | Wolfe ResearchAndy Chen |
Downgrades | Outperform → Peer perform | — |
| 2025-11-11 | Jones TradingDebanjana Chatterjee |
Downgrades | Buy → Hold | — |
| 2025-11-11 | Evercore ISI GroupJonathan Miller |
Downgrades | Outperform → In-line | $17 → $8 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $11.91
- Market Cap
- $1.67 billion
- 52-Week Range
- $7.95 – $28.25
- Average Volume
- 3.97 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.